Overview

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to evaluate the overall effectiveness of 8 week of aripiprazole treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborator:
Otsuka America Pharmaceutical
Treatments:
Aripiprazole